Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adam Dean is active.

Publication


Featured researches published by Adam Dean.


Aging Cell | 2007

Alterations in xenobiotic metabolism in the long‐lived Little mice

Daniel Amador-Noguez; Adam Dean; Wendong Huang; Kenneth D. R. Setchell; David D. Moore; Gretchen J. Darlington

Our previous microarray expression analysis of the long‐lived Little mice (Ghrhrlit/lit) showed a concerted up‐regulation of xenobiotic detoxification genes. Here, we show that this up‐regulation is associated with a potent increase in resistance against the adverse effects of a variety of xenobiotics, including the hepatotoxins acetaminophen and bromobenzene and the paralyzing agent zoxazolamine. The classic xenobiotic receptors Car (Constitutive Androstane Receptor) and Pxr (Pregnane X Receptor) are considered key regulators of xenobiotic metabolism. Using double and triple knockout/mutant mouse models we found, however, that Car and Pxr are not required for the up‐regulation of xenobiotic genes in Little mice. Our results suggest instead that bile acids and the primary bile acid receptor Fxr (farnesoid X receptor) are likely mediators of the up‐regulation of xenobiotic detoxification genes in Little mice. Bile acid levels are considerably elevated in the bile, serum, and liver of Little mice. We found that treatment of wild‐type animals with cholic acid, one of the major bile acids elevated in Little mice, mimics in large part the up‐regulation of xenobiotic detoxification genes observed in Little mice. Additionally, the loss of Fxr had a major effect on the expression of the xenobiotic detoxification genes up‐regulated in Little mice. A large fraction of these genes lost or decreased their high expression levels in double mutant mice for Fxr and Ghrhr. The alterations in xenobiotic metabolism in Little mice constitute a form of increased stress resistance and may contribute to the extended longevity of these mice.


Stem Cells and Development | 2011

CD24-Positive Cells from Normal Adult Mouse Liver Are Hepatocyte Progenitor Cells

Qiong Qiu; Julio Cesar Hernandez; Adam Dean; Pulivarthi H. Rao; Gretchen J. Darlington

The identification of specific cell surface markers that can be used to isolate liver progenitor cells will greatly facilitate experimentation to determine the role of these cells in liver regeneration and their potential for therapeutic transplantation. Previously, the cell surface marker, CD24, was observed to be expressed on undifferentiated bipotential mouse embryonic liver stem cells and 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced oval cells. Here, we describe the isolation and characterization of a rare, primary, nonhematopoietic, CD24+ progenitor cell population from normal, untreated mouse liver. By immunohistochemistry, CD24-expressing cells in normal adult mouse liver were colocalized with CK19-positive cholangiocytes. This nonhematopoietic (CD45-, Ter119-) CD24+ cell population isolated by flow cytometry represented 0.04% of liver cells and expressed several markers of liver progenitor/oval cells. The immunophenotype of nonhematopoietic CD24+ cells was CD133, Dlk, and Sca-1 high, but c-Kit, Thy-1, and CD34 low. The CD24+ cells had increased expression of CK19, epithelial cell adhesion molecule, Sox 9, and FN14 compared with the unsorted cells. Upon transplantation of nonhematopoietic CD24+ cells under the sub-capsule of the livers of Fah knockout mice, cells differentiated into mature functional hepatocytes. Analysis of X and Y chromosome complements were used to determine whether or not fusion of the engrafted cells with the recipient hepatocytes occurred. No cells were found that contained XXXY or any other combination of donor and host sex chromosomes as would be expected if cell fusion had occurred. These results suggested that CD24 can be used as a cell surface marker for isolation of hepatocyte progenitor cells from normal adult liver that are able to differentiate into hepatocytes.


Hepatology | 2008

Lymphoid neogenesis and immune infiltration in aged liver.

Pallavi Singh; Zeynep Z. Coskun; Catriona Goode; Adam Dean; LuAnn Thompson-Snipes; Gretchen J. Darlington

Immune dysregulation and inflammation play a major role in the pathology of age‐related disorders. In an earlier study, the microarray data from our laboratory indicated an increase in inflammation‐related gene expression in the liver with age. We further investigated immune‐related changes in the aged liver and found that the levels of inflammatory cytokines, chemokines, and inflammatory genes were higher in aged animals. Immunohistochemical studies showed that immune cells formed clusters or foci in the livers of old mice, preferentially near the perivascular regions. Further analysis revealed an enrichment of macrophages, T cells, B cells, natural killer cells, and neutrophils in old liver. Characterization of the immune clusters showed the presence of shared markers of tertiary lymphoid neogenesis. Levels of lymph node homing cytokines were elevated. Expression of immunoglobulin and recombinase gene transcripts was also higher, indicating the presence of ectopic lymphoid structures in the aged liver. Conclusion: Aged liver exhibits a marked inflammatory status accompanied by increased immune cell infiltration. Inflammation and ectopic lymphoid structures have previously been shown to be associated with carcinogenesis, a condition that becomes more prevalent with age. Thus, further study of inflammation‐related changes in the microenvironment of the aged liver could provide insights into these disorders. (HEPATOLOGY 2008.)


Stem Cells | 2007

Transcriptional Profiling of Bipotential Embryonic Liver Cells to Identify Liver Progenitor Cell Surface Markers

Scott A. Ochsner; Helene Strick-Marchand; Qiong Qiu; Susan Venable; Adam Dean; Margaret Wilde; Mary C. Weiss; Gretchen J. Darlington

The ability to purify to homogeneity a population of hepatic progenitor cells from adult liver is critical for their characterization prior to any therapeutic application. As a step in this direction, we have used a bipotential liver cell line from 14 days postcoitum mouse embryonic liver to compile a list of cell surface markers expressed specifically by liver progenitor cells. These cells, known as bipotential mouse embryonic liver (BMEL) cells, proliferate in an undifferentiated state and are capable of differentiating into hepatocyte‐like and cholangiocyte‐like cells in vitro. Upon transplantation, BMEL cells are capable of differentiating into hepatocytes and cholangiocytes in vivo. Microarray and Gene Ontology (GO) analysis of gene expression in the 9A1 and 14B3 BMEL cell lines grown under proliferating and differentiating conditions was used to identify cell surface markers preferentially expressed in the bipotential undifferentiated state. This analysis revealed that proliferating BMEL cells express many genes involved in cell cycle regulation, whereas differentiation of BMEL cells by cell aggregation causes a switch in gene expression to functions characteristic of mature hepatocytes. In addition, microarray data and protein analysis indicated that the Notch signaling pathway could be involved in maintaining BMEL cells in an undifferentiated stem cell state. Using GO annotation, a list of cell surface markers preferentially expressed on undifferentiated BMEL cells was generated. One marker, Cd24a, is specifically expressed on progenitor oval cells in livers of diethyl 1,4‐dihydro‐2,4,6‐trimethyl‐3,5‐pyridinedicarboxylate‐treated animals. We therefore consider Cd24a expression a candidate molecule for purification of hepatic progenitor cells.


Hepatology | 2015

The CaMKK2/CaMKIV Relay Is an Essential Regulator of Hepatic Cancer

Fumin Lin; Kathrina L. Marcelo; Kimal Rajapakshe; Cristian Coarfa; Adam Dean; Nathaniel Wilganowski; Holly Robinson; Eva M. Sevick; Karl-Dimiter Bissig; Lauren C. Goldie; Anthony R. Means; Brian York

Hepatic cancer is one of the most lethal cancers worldwide. Here, we report that the expression of Ca2+/calmodulin‐dependent protein kinase kinase 2 (CaMKK2) is significantly up‐regulated in hepatocellular carcinoma (HCC) and negatively correlated with HCC patient survival. The CaMKK2 protein is highly expressed in all eight hepatic cancer cell lines evaluated and is markedly up‐regulated relative to normal primary hepatocytes. Loss of CaMKK2 function is sufficient to inhibit liver cancer cell growth, and the growth defect resulting from loss of CaMKK2 can be rescued by ectopic expression of wild‐type CaMKK2 but not by kinase‐inactive mutants. Cellular ablation of CaMKK2 using RNA interference yields a gene signature that correlates with improvement in HCC patient survival, and ablation or pharmacological inhibition of CaMKK2 with STO‐609 impairs tumorigenicity of liver cancer cells in vivo. Moreover, CaMKK2 expression is up‐regulated in a time‐dependent manner in a carcinogen‐induced HCC mouse model, and STO‐609 treatment regresses hepatic tumor burden in this model. Mechanistically, CaMKK2 signals through Ca2+/calmodulin‐dependent protein kinase 4 (CaMKIV) to control liver cancer cell growth. Further analysis revealed that CaMKK2 serves as a scaffold to assemble CaMKIV with key components of the mammalian target of rapamycin/ribosomal protein S6 kinase, 70 kDa, pathway and thereby stimulate protein synthesis through protein phosphorylation. Conclusion: The CaMKK2/CaMKIV relay is an upstream regulator of the oncogenic mammalian target of rapamycin/ribosomal protein S6 kinase, 70 kDa, pathway, and the importance of this CaMKK2/CaMKIV axis in HCC growth is confirmed by the potent growth inhibitory effects of genetically or pharmacologically decreasing CaMKK2 activity; collectively, these findings suggest that CaMKK2 and CaMKIV may represent potential targets for hepatic cancer. (Hepatology 2015;62:505–520


Proceedings of the National Academy of Sciences of the United States of America | 2015

SRC-2 orchestrates polygenic inputs for fine-tuning glucose homeostasis

Tiffany Fleet; Bin Zhang; Fumin Lin; Bokai Zhu; Subhamoy Dasgupta; Erin Stashi; Bryan Tackett; Sundararajah Thevananther; Kimal Rajapakshe; Naomi Gonzales; Adam Dean; Jianqiang Mao; Nikolai A. Timchenko; Anna Malovannaya; Jun Qin; Cristian Coarfa; Francesco J. DeMayo; Clifford C. Dacso; Charles E. Foulds; Bert W. O'Malley; Brian York

Significance Maintenance of glucose concentrations within a homeostatic range is essential for preserving the function of glucose-sensitive tissues. Perturbations in the mechanisms that control this homeostasis give rise to a continuum of glucopathologies associated with aberrant carbohydrate metabolism. Here we show Steroid Receptor Coactivator 2 (SRC-2) to be an integral coregulator that couples gene output with energetic demand by stabilizing and amplifying transcriptional complexes. This study highlights the collective importance of transcriptional coregulators for coordination of gene expression events and may provide insight for understanding components of polygenic diseases such as type 2 diabetes mellitus. Despite extensive efforts to understand the monogenic contributions to perturbed glucose homeostasis, the complexity of genetic events that fractionally contribute to the spectrum of this pathology remain poorly understood. Proper maintenance of glucose homeostasis is the central feature of a constellation of comorbidities that define the metabolic syndrome. The ability of the liver to balance carbohydrate uptake and release during the feeding-to-fasting transition is essential to the regulation of peripheral glucose availability. The liver coordinates the expression of gene programs that control glucose absorption, storage, and secretion. Herein, we demonstrate that Steroid Receptor Coactivator 2 (SRC-2) orchestrates a hierarchy of nutritionally responsive transcriptional complexes to precisely modulate plasma glucose availability. Using DNA pull-down technology coupled with mass spectrometry, we have identified SRC-2 as an indispensable integrator of transcriptional complexes that control the rate-limiting steps of hepatic glucose release and accretion. Collectively, these findings position SRC-2 as a major regulator of polygenic inputs to metabolic gene regulation and perhaps identify a previously unappreciated model that helps to explain the clinical spectrum of glucose dysregulation.


Scientific Reports | 2017

Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD

Brian York; Feng Li; Fumin Lin; Kathrina L. Marcelo; Jianqiang Mao; Adam Dean; Naomi Gonzales; David M. Gooden; Suman Maity; Cristian Coarfa; Nagireddy Putluri; Anthony R. Means

Binding of calcium to its intracellular receptor calmodulin (CaM) activates a family of Ca2+/CaM-dependent protein kinases. CaMKK2 (Ca2+/CaM-dependent protein kinase kinase 2) is a central member of this kinase family as it controls the actions of a CaMK cascade involving CaMKI, CaMKIV or AMPK. CaMKK2 controls insulin signaling, metabolic homeostasis, inflammation and cancer cell growth highlighting its potential as a therapeutic target for a variety of diseases. STO-609 is a selective, small molecule inhibitor of CaMKK2. Although STO-609 has been used extensively in vitro and in cells to characterize and define new mechanistic functions of CaMKK2, only a few studies have reported the in vivo use of STO-609. We synthesized functional STO-609 and assessed its pharmacological properties through in vitro (kinase assay), ex vivo (human liver microsomes) and in vivo (mouse) model systems. We describe the metabolic processing of STO-609, its toxicity, pharmacokinetics and bioavailability in a variety of mouse tissues. Utilizing these data, we show STO-609 treatment to inhibit CaMKK2 function confers protection against non-alcoholic fatty liver disease. These data provide a valuable resource by establishing criteria for use of STO-609 to inhibit the in vivo functions of CaMKK2 and demonstrate its utility for treating metabolically-related hepatic disease.


Cell Reports | 2014

SRC-2 Is an Essential Coactivator for Orchestrating Metabolism and Circadian Rhythm

Erin Stashi; Rainer B. Lanz; Jianqiang Mao; George Michailidis; Bokai Zhu; Nicole M. Kettner; Nagireddy Putluri; Erin L. Reineke; Lucas C. Reineke; Subhamoy Dasgupta; Adam Dean; Connor R. Stevenson; Natarajan Sivasubramanian; Arun Sreekumar; Francesco J. DeMayo; Brian York; Loning Fu; Bert W. O'Malley


Molecular Cell | 2015

Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading

Bokai Zhu; Leah A. Gates; Erin Stashi; Subhamoy Dasgupta; Naomi Gonzales; Adam Dean; Clifford C. Dacso; Brian York; Bert W. O'Malley


Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2011

Elevated Interferon Gamma Signaling Contributes to Impaired Regeneration in the Aged Liver

Pallavi Singh; Triona Goode; Adam Dean; Samir S. Awad; Gretchen J. Darlington

Collaboration


Dive into the Adam Dean's collaboration.

Top Co-Authors

Avatar

Brian York

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cristian Coarfa

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Fumin Lin

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Naomi Gonzales

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bert W. O'Malley

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Bokai Zhu

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Erin Stashi

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Jianqiang Mao

Baylor College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge